Phase I safety Evaluation of HQMZ111831 in Healthy Female Volunteers
Phase 1
- Registration Number
- CTRI/2019/03/017991
- Lead Sponsor
- The Himalaya Drug Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Healthy Adult female volunteers.
2)Aged >=18 to <= 45 years.
3)Subjects willing to sign the informed consent.
4)Subjects to be refrained to take any other similar kind of intervention during the study period.
Exclusion Criteria
1)Subjects clinically diagnosed with any clinically significant systemic disorder.
2)Subjects on any other nutritional supplements.
3)A known history or present condition of allergic response to pharmaceutical products its components or ingredients in the test products.
4)Genetic and Endocrinal disorders.
5)Has participated in a similar clinical investigation in the past four weeks.
6)Subjectâ??s parents who refused to sign informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method